ReLive Biotechnologies LTD Funding: $36M Raised, Series A
ReLive Biotechnologies LTD is based in Nanjing, Jiangsu, China. It has raised $36M in total funding. Latest round: Series A. Backed by SHC.
ReLive Biotechnologies LTD funding overview
ReLive Biotechnologies LTD is based in Nanjing, Jiangsu, China. ReLive Biotechnologies LTD has raised $36M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A. Investors on record include SHC.
ReLive Biotechnologies LTD at a glance
Total raised
$36M
Latest round
Series A
Headquarters
Nanjing, Jiangsu, China
Notable investors
SHC
Frequently asked about ReLive Biotechnologies LTD funding
How much has ReLive Biotechnologies LTD raised?
ReLive Biotechnologies LTD has raised $36M in total disclosed funding across the rounds on record.
Who has invested in ReLive Biotechnologies LTD?
SHC are named among the investors backing ReLive Biotechnologies LTD.
What was the latest ReLive Biotechnologies LTD funding round?
The most recent disclosed round is a Series A.
Where is ReLive Biotechnologies LTD based?
ReLive Biotechnologies LTD is based in Nanjing, Jiangsu, China.
We update the ReLive Biotechnologies LTD record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Nanjing and their backers are listed below.
Companies related to ReLive Biotechnologies LTD (18)
